Literature DB >> 33588522

Beyond multimorbidity: What can we learn from complexity science?

Joachim P Sturmberg1,2, Linn O Getz3, Kurt C Stange4, Ross E G Upshur5, Stewart W Mercer6.   

Abstract

Multimorbidity - the occurrence of two or more long-term conditions in an individual - is a major global concern, placing a huge burden on healthcare systems, physicians, and patients. It challenges the current biomedical paradigm, in particular conventional evidence-based medicine's dominant focus on single-conditions. Patients' heterogeneous range of clinical presentations tend to escape characterization by traditional means of classification, and optimal management cannot be deduced from clinical practice guidelines. In this article, we argue that person-focused care based in complexity science may be a transformational lens through which to view multimorbidity, to complement the specialism focus on each particular disease. The approach offers an integrated and coherent perspective on the person's living environment, relationships, somatic, emotional and cognitive experiences and physiological function. The underlying principles include non-linearity, tipping points, emergence, importance of initial conditions, contextual factors and co-evolution, and the presence of patterned outcomes. From a clinical perspective, complexity science has important implications at the theoretical, practice and policy levels. Three essential questions emerge: (1) What matters to patients? (2) How can we integrate, personalize and prioritize care for whole people, given the constraints of their socio-ecological circumstances? (3) What needs to change at the practice and policy levels to deliver what matters to patients? These questions have no simple answers, but complexity science principles suggest a way to integrate understanding of biological, biographical and contextual factors, to guide an integrated approach to the care of people with multimorbidity.
© 2021 John Wiley & Sons, Ltd.

Entities:  

Keywords:  complexity science; health; multimorbidity; person-centered care

Year:  2021        PMID: 33588522     DOI: 10.1111/jep.13521

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  6 in total

1.  Mental-physical multimorbidity treatment adherence challenges in Brazilian primary care: A qualitative study with patients and their healthcare providers.

Authors:  Magdalena Rzewuska; Ana Carolina Guidorizzi Zanetti; Zoë C Skea; Leonardo Moscovici; Camila Almeida de Oliveira; João Mazzoncini de Azevedo-Marques
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

2.  Health complexity assessment in primary care: A validity and feasibility study of the INTERMED tool.

Authors:  Camila Almeida de Oliveira; Bernardete Weber; Jair Lício Ferreira Dos Santos; Miriane Lucindo Zucoloto; Lisa Laredo de Camargo; Ana Carolina Guidorizzi Zanetti; Magdalena Rzewuska; João Mazzoncini de Azevedo-Marques
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

3.  Primary health care case management through the lens of complexity: an exploratory study of naturopathic practice using complexity science principles.

Authors:  Kim D Graham; Amie Steel; Jon Wardle
Journal:  BMC Complement Med Ther       Date:  2022-04-15

4.  A codesigned fit-for-purpose implementation framework for aged care.

Authors:  Claudia Meyer; Rajna Ogrin; Xanthe Golenko; Elizabeth Cyarto; Kath Paine; Willeke Walsh; Alison Hutchinson; Judy Lowthian
Journal:  J Eval Clin Pract       Date:  2022-02-06       Impact factor: 2.336

5.  There is More to 'Making Connections to Improve Health Outcomes'.

Authors:  Joachim Sturmberg
Journal:  Glob Adv Health Med       Date:  2022-09-21

6.  Healthcare needs, experiences and treatment burden in primary care patients with multimorbidity: An evaluation of process of care from patients' perspectives.

Authors:  Xiu-Jing Hu; Harry H X Wang; Yu-Ting Li; Xiao-Ya Wu; Yi Wang; Jia-Heng Chen; Jia-Ji Wang; Samuel Y S Wong; Stewart W Mercer
Journal:  Health Expect       Date:  2021-09-28       Impact factor: 3.377

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.